Skip to main content
. Author manuscript; available in PMC: 2009 Oct 2.
Published in final edited form as: Eur J Neurosci. 2009 May 21;29(11):2177–2186. doi: 10.1111/j.1460-9568.2009.06764.x

Fig. 2.

Fig. 2

Measurement of DA and DOPAC levels and DA turnover (DOPAC/DA) in the dorsal striatum (A) and ventral midbrain (B). Saline or MPTP (4x 20 mg/kg, i.p.) were administered every 2 hr on day 0. Vehicle or WIN (4 mg/kg, i.p.) were administered every day over a 5 day period, starting 24 hr after the last injection of MPTP. Animals were sacrificed on day 7 post-MPTP treatment. *p<0.05 and **p<0.01 compared to saline+vehicle; #p<0.05 compared to MPTP+vehicle (ANOVA followed by Newman-Keuls’ multiple comparisons post-test; n=4 per treatment).